Heart Failure: Implications for Quality Improvement and Hands-on Training
This Continuing Education activity is supported by an educational grant from Novartis Pharmaceuticals Corporation..
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation..
Sneha Baxi Srivastava, PharmD, BCACP, CDE
Clinical Associate ProfessorChicago State University College of PharmacyChicago, IllinoisClinical PharmacistACCESS Community Health NetworkChicago, Illinois
After completing this continuing education program, the participant will be able to:
- Apply guideline-directed medical therapies to patients with heart failure
- Identify the role of newer therapies for heart failure
- Explore the role of the pharmacist in management of heart failure in the inpatient, transitional, and outpatient settings
- Demonstrate patient counseling skills to provide optimal patient-centered care for patients with heart failure
Target audience: Pharmacists, including community and health-systems pharmacists
Type of activity: Application
Release date: October 31, 2016
Expiration date: November 30, 2017
Estimated time to complete activity: 3.0 hours
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.30 CEUs) under the ACPE universal activity number 0290-0000-16-141-H01-P. The activity is available for CE credit through November 30, 2017.